Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

ClinicalTrials.gov ID: NCT04599855

Public ClinicalTrials.gov record NCT04599855. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 5:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of each individual dose of esketamine nasal spray, 56 milligram (mg) and 84 mg, compared with placebo nasal spray in improving depressive symptoms in participants with treatment resistant depression (TRD), as assessed by the change from baseline in the Montgomery-Asberg Depression Rating Scale (MADRS) total score from Day 1 (prerandomization) to the end of the 4 week double-blind treatment phase (Day 28).

Study identification

NCT ID
NCT04599855
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
477 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 4, 2020 (Actual)
Primary completion
Jan 31, 2024 (Actual)
Completion
Jan 31, 2024 (Actual)
Last update posted
Apr 25, 2025

2020 – 2024

United States locations

U.S. sites
54
U.S. states
19
U.S. cities
47
Facility City State ZIP Site status
UAB Department of Psychiatry and Behavioral Neurobiology Birmingham Alabama 35294 —
UAB Huntsville Regional Medical Campus Huntsville Alabama 35801 —
Preferred Research Partners Little Rock Arkansas 72211 —
Behavioral Research Specialists LLC Glendale California 91206 —
CalNeuro Research Los Angeles California 90025 —
Pacific Research Partners Oakland California 94607 —
Anderson Clinical Research Redlands California 92374 —
University of California at San Diego San Diego California 92103-8620 —
Artemis Institute for Clinical Research San Diego California 92103 —
UCSF Nancy Friend Pritzker Psychiatry Building San Francisco California 94143 —
Velocity Clinical Research Santa Ana California 91704 —
CMB Clinical Trials Santee California 92071 —
University of Connecticut Health Center Farmington Connecticut 06032 —
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009 —
Accel Research Sites Lakeland Florida 33803 —
APG Research LLC Orlando Florida 32803 —
USF, Department of Psychiatry and Behavioral Neurosciences Tampa Florida 33613 —
Neuroscience Research Institute West Palm Beach Florida 33407 —
Atlanta Behavioral Research, LLC Atlanta Georgia 30338 —
Psych Atlanta, P.C. Marietta Georgia 30060 —
Rush University Medical Center Chicago Illinois 60612 —
Chicago Research Center Chicago Illinois 60634 —
University of Chicago Chicago Illinois 60637 —
Joliet Center for Clinical Research Joliet Illinois 60435 —
Pillar Clinical Research, LLC Lincolnwood Illinois 60712 —
Psychiatric Medicine Associates LLC Skokie Illinois 60076 —
Ascension via Christi Research Wichita Kansas 67214 —
University of Kansas School of Medicine Wichita Kansas 67214 —
Sheppard Pratt Health System Baltimore Maryland 21204 —
CBH Health Gaithersburg Maryland 20877 —
Copley Clinical Boston Massachusetts 02116 —
Adams Clinical Watertown Massachusetts 02472 —
University of Massachusetts Medical School Worcester Massachusetts 01655 —
University of Michigan Ann Arbor Michigan 48109 —
Rochester Center for Behavioral Medicine (RCBM) Rochester Hills Michigan 48307 —
Midwest Research Group - St. Charles Psychiatric Associates Saint Charles Missouri 63304 —
Clinilabs New York New York 10016 —
The Medical Research Network, LLC New York New York 10128 —
Stony Brook University Medical Center Stony Brook New York 11794 —
Ohio State University Columbus Ohio 43210 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Paradigm Research Professionals, LLC Oklahoma City Oklahoma 73118 —
Lehigh Center for Clinical Research Allentown Pennsylvania 18104 —
University of Pennsylvania Medical Center Philadelphia Pennsylvania 19104 —
The Warren Alpert Medical School of Brown University - Butler Hospital Providence Rhode Island 02906 —
BioBehavioral Research of Austin PC Austin Texas 78759 —
Relaro Medical Trials Dallas Texas 75243 —
University of Texas Southwestern Medical Center Dallas Texas 75247 —
Brain Health Consultants and TMS Center Houston Texas 77046 —
The University of Texas Health Science Center at Houston Houston Texas 77054 —
Pillar Clinical Research, LLC Richardson Texas 75080 —
Family Psychiatry of The Woodlands The Woodlands Texas 77381 —
Grayline Research Center Wichita Falls Texas 76309 —
University of Virginia Center for Psychiatric Clinical Research Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04599855, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2025 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04599855 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →